NCT06334042View on ClinicalTrials.gov

Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

August 8, 2024

Study Completion Date

August 14, 2024

Conditions
Chromium DeficiencyDiabetes MellitusHyperlipidemiasHypercholesterolemia
Interventions
DIAGNOSTIC_TEST

Serum Chromium Level

Measuring serum chromium levels from patients who admitted in intensive care unit.

Trial Locations (1)

06230

Hacettepe University, Ankara

All Listed Sponsors
lead

Oguzhan Kahveci

OTHER

NCT06334042 - Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit | Biotech Hunter | Biotech Hunter